Dec. 22, 2025

WRAIR-EME monitors for disease threats at Agile Spirit 2025

The Walter Reed Army Institute of Research-Europe—Middle East conducted infectious disease surveillance in support of Agile Spirit 2025 from 25 July – 6 August, 2025 in the Country of Georgia.

Dec. 11, 2025

WRAIR creates dose-response curve to predict the effects of blast overpressure

In June 2025, the Walter Reed Army Institute of Research began developing dose-response curves which use a mathematical formula to describe the relationship between blast exposure during military training and its health consequences. Dose-response curves allow military training to be optimized so that it meets critical learning goals for service members while minimizing health risks.

Dec. 1, 2025

WRAIR-EME protects force health with vector surveillance at Eagle Partner 2025

The Walter Reed Army Institute of Research Europe-Middle East conducted vector surveillance in support of exercise Eagle Partner from 8 to 11 July at military bases in Armenia.

Nov. 25, 2025

HIV Sequencing Sheds Light on Rapidly Growing Philippines Epidemic

While HIV is declining globally, the Philippines stands in stark contrast, experiencing a 411% increase in daily incidence between 2012 and 2023, as reported to the HIV/AIDS and ART Registry of the Philippines. Now recognized as the fastest growing HIV epidemic in the Western Pacific region, the country is facing a mounting public health challenge with limited data on the virus’ regional molecular epidemiology.

Nov. 25, 2025

WRAIR develops Leadership in Moral Awareness training to protect against moral injury

Over the last four years, research psychologists at the Walter Reed Army Institute of Research have been developing a new training to proactively address moral injury in service members.

Nov. 24, 2025

WRAIR’s Cryo EM Lab Delivers Near Atomic Visualization to Speed Military Medical Countermeasure Development

The Walter Reed Army Institute of Research (WRAIR) is leveraging advanced cryo-electron microscopy (cryo-EM) capabilities and expertise cultivated in-house to develop next-generation prevention and therapeutic medical countermeasures to protect the health of U.S. service members and ensure Force Readiness and Resiliency.